Record Details

Sardegna

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Sardegna
 
Creator Cavallo, Maria Caterina
Cipriani, Filippo
Gerzeli, Simone
Demarteau, Nadia
Marocco, Alessia
Bamfi, Francesco
 
Subject Pharmacoeconomics; Health economics
Sardinia; HPV vaccination; Economic & clinical impact
 
Description In Sardinia region 45,5% of women (aged 25-64) are screened regularly, meaning every 3 years.
Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 38 cases of cervicocarcinoma and 15 related deaths and thus results to be cost-effective (15.347 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 41 cancer cases and 18 deaths could be prevented, with a very similar cost-effectiveness ratio. In Sardinia region, the net cost for woman vaccinated is 148 € for the single cohort and 152 € for the multiple cohort.
 
Publisher SEEd
 
Date 2008-09-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format application/pdf
 
Identifier http://journals.edizioniseed.it/index.php/FE/article/view/1019
10.7175/fe.v9i1S.1019
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 9, No 1S (2008); 91-93
2240-256X
1721-6915
 
Language eng
 
Relation http://journals.edizioniseed.it/index.php/FE/article/view/1019/1237